COSCIENS Biopharma Inc. (CSCIF)
OTCMKTS
· Delayed Price · Currency is USD
2.060
-0.020 (-0.97%)
At close: Dec 4, 2025
COSCIENS Biopharma Employees
COSCIENS Biopharma had 40 employees as of December 31, 2024. The number of employees increased by 28 or 233.33% compared to the previous year.
Employees
40
Change
28
Growth
233.33%
Revenue / Employee
$226,350
Profits / Employee
-$372,650
Market Cap
6.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40 | 28 | 233.33% |
| Dec 31, 2020 | 12 | -44 | -78.57% |
| Dec 31, 2014 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
COSCIENS Biopharma News
- 4 days ago - COSCIENS Announces Exclusive Distribution Agreement with Wuzhou Drug International for Macrilen® in Hainan-Guangdong-Hong Kong-Macao Greater Bay Area and Singapore - GlobeNewsWire
- 21 days ago - COSCIENS Biopharma Inc. Announces Leadership Change - GlobeNewsWire
- 4 months ago - COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update - GlobeNewsWire
- 5 months ago - COSCIENS Biopharma Announces Results of Virtual 2025 Meeting of Shareholders - GlobeNewsWire
- 6 months ago - COSCIENS Biopharma Inc. Acknowledges Receipt of Intended Director Nominations from Goodwood for the Upcoming Annual and Special Meeting of Shareholders - GlobeNewsWire
- 7 months ago - COSCIENS Biopharma Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 8 months ago - COSCIENS Biopharma Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 8 months ago - COSCIENS Biopharma Inc. Announces Receipt of Management Cease Trade Order - GlobeNewsWire